"Mastocytosis, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
Concept/Terms
Mastocytosis, Systemic- Mastocytosis, Systemic
- Mastocytoses, Systemic
- Systemic Mastocytoses
- Systemic Mastocytosis
- Systemic Mast-Cell Disease
- Mast-Cell Disease, Systemic
- Mast-Cell Diseases, Systemic
- Systemic Mast Cell Disease
- Systemic Mast-Cell Diseases
Indolent Systemic Mastocytosis- Indolent Systemic Mastocytosis
- Indolent Systemic Mastocytoses
- Mastocytoses, Indolent Systemic
- Mastocytosis, Indolent Systemic
- Systemic Mastocytoses, Indolent
- Systemic Mastocytosis, Indolent
Aggressive Systemic Mastocytosis- Aggressive Systemic Mastocytosis
- Aggressive Systemic Mastocytoses
- Mastocytoses, Aggressive Systemic
- Mastocytosis, Aggressive Systemic
- Systemic Mastocytoses, Aggressive
- Systemic Mastocytosis, Aggressive
Below are MeSH descriptors whose meaning is more general than "Mastocytosis, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Mastocytosis, Systemic".
This graph shows the total number of publications written about "Mastocytosis, Systemic" by people in Harvard Catalyst Profiles by year, and whether "Mastocytosis, Systemic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 5 | 0 | 5 |
| 2015 | 4 | 1 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 6 | 0 | 6 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 7 | 0 | 7 |
Below are the most recent publications written about "Mastocytosis, Systemic" by people in Profiles.
-
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial. Nat Med. 2021 12; 27(12):2192-2199.
-
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial. Nat Med. 2021 12; 27(12):2183-2191.
-
Finding the right KIT inhibitor for advanced systemic mastocytosis. Nat Med. 2021 12; 27(12):2081-2082.
-
GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness. Blood. 2021 10 28; 138(17):1590-1602.
-
Treatment of systemic mastocytosis: Novel and emerging therapies. Ann Allergy Asthma Immunol. 2021 10; 127(4):412-419.
-
Co-occurrence of immune-mediated conditions and endometriosis among adolescents and adult women. Am J Reprod Immunol. 2021 07; 86(1):e13404.
-
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis. J Allergy Clin Immunol. 2021 03; 147(3):877-878.
-
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions. J Allergy Clin Immunol. 2020 08; 146(2):300-306.
-
Introduction to a review series on rare systemic hematologic disorders. Blood. 2020 04 16; 135(16):1305.
-
Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergy. J Allergy Clin Immunol Pract. 2020 Feb; 8(2):780-782.